Nucleus Network is Australia’s largest and only global multi-site dedicated phase I clinical research organisation with phase I facilities located in Melbourne (80 beds), Brisbane (62 beds) and  Minnesota (52 beds).  The phase I units in Australia are strategically co-located within the Alfred Hospital in Melbourne (approx. 800 bed tertiary teaching hospital) and within the Royal Brisbane and Women’s Hospital (approx. 900 bed tertiary teaching hospital) in Brisbane. This combination also provides Nucleus Network with access to a combined population of 7.5 million people within Australia alone.

Nucleus Network have extensive experience in the conduct of early phase study designs in healthy volunteers and patient populations eg. FIH SAD and MAD, drug interaction, food effect, bioequivalence, crossover, TQTc, ethnopharmacology, etc. Established in 2004, Nucleus Network has conducted over 750 phase I clinical trials, with 90% of clients being overseas (primarily the USA) pharmaceutical and biotech companies. Approximately 70 phase I studies are conducted annually per year at Nucleus with about 30 of these being true first-in-human studies. Nucleus has extensive experience with both biologics and small molecule products across most therapeutic areas.